The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).
Daniel EigerMarcio WagnerNoam Falbel PondéMelanie Schmitt NogueiraLaurence BuisseretEvandro de AzambujaPublished in: Acta oncologica (Stockholm, Sweden) (2020)